Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	serpin family protein binding	CTSL CTSV	6.14e-06	2	50	2	GO:0097655
GeneOntologyMolecularFunction	latrotoxin receptor activity	ADGRL1 ADGRL2	6.14e-06	2	50	2	GO:0016524
GeneOntologyMolecularFunction	cysteine-type carboxypeptidase activity	CTSL CTSV	3.68e-05	4	50	2	GO:0016807
GeneOntologyMolecularFunction	kininogen binding	CTSL CTSV	6.12e-05	5	50	2	GO:0030984
GeneOntologyMolecularFunction	cysteine-type exopeptidase activity	CTSL CTSV	2.73e-04	10	50	2	GO:0070004
GeneOntologyBiologicalProcess	maintenance of postsynaptic specialization structure	CADM1 PRICKLE2 ADGRL3	8.90e-06	17	50	3	GO:0098880
GeneOntologyBiologicalProcess	synapse assembly	CADM1 DKK1 DOCK7 PRICKLE2 ADGRL1 ADGRL2 ADGRL3	8.91e-06	308	50	7	GO:0007416
GeneOntologyBiologicalProcess	postsynaptic specialization organization	CADM1 DOCK7 PRICKLE2 ADGRL3	2.63e-05	71	50	4	GO:0099084
GeneOntologyBiologicalProcess	synapse organization	CADM1 DKK1 DOCK7 PRICKLE2 ADGRL1 SPG11 ACTL9 ADGRL2 ADGRL3	3.45e-05	685	50	9	GO:0050808
GeneOntologyBiologicalProcess	maintenance of synapse structure	CADM1 PRICKLE2 ADGRL3	1.24e-04	40	50	3	GO:0099558
GeneOntologyBiologicalProcess	regulation of synapse assembly	DKK1 PRICKLE2 ADGRL1 ADGRL2 ADGRL3	1.27e-04	202	50	5	GO:0051963
GeneOntologyBiologicalProcess	catagen	CTSL CTSV	2.05e-04	9	50	2	GO:0042637
MousePheno	periodontal ligament necrosis	CTSL CTSV	6.45e-06	2	36	2	MP:0030515
MousePheno	abnormal lymph node medullary sinus morphology	CTSL CTSV	6.45e-06	2	36	2	MP:0011222
MousePheno	dilated lymph node medullary sinus	CTSL CTSV	6.45e-06	2	36	2	MP:0011223
MousePheno	rough coat	CTSL CTSV EPG5	3.06e-05	24	36	3	MP:0010179
MousePheno	folliculitis	CTSL CTSV	6.42e-05	5	36	2	MP:0000376
MousePheno	dental pulp necrosis	CTSL CTSV	6.42e-05	5	36	2	MP:0013251
MousePheno	hair follicle outer root sheath hyperplasia	CTSL CTSV	6.42e-05	5	36	2	MP:0010688
MousePheno	enlarged thymus cortex	CTSL CTSV	6.42e-05	5	36	2	MP:0013593
MousePheno	amyloidosis	PSAP CTSL CTSV	9.70e-05	35	36	3	MP:0000604
MousePheno	abnormal amyloid deposition	PSAP CTSL CTSV	9.70e-05	35	36	3	MP:0021152
MousePheno	granulomatous inflammation	IL31RA CTSL CTSV	1.06e-04	36	36	3	MP:0002500
MousePheno	mitral valve regurgitation	CTSL CTSV	1.34e-04	7	36	2	MP:0006045
MousePheno	abnormal R wave	CTSL CTSV	1.34e-04	7	36	2	MP:0011919
MousePheno	increased effector memory CD4-positive, alpha-beta T cell number	ZC3H12C CTSL CTSV	1.56e-04	41	36	3	MP:0010844
MousePheno	dilated piliary canal	CTSL CTSV	1.79e-04	8	36	2	MP:0030571
MousePheno	sparse vibrissae	CTSL CTSV	1.79e-04	8	36	2	MP:0001283
MousePheno	stereotypic behavior	PSAP CTSL CTSV ADGRL3 EPG5	2.06e-04	214	36	5	MP:0001408
MousePheno	abnormal hair cycle catagen phase	CTSL CTSV	2.30e-04	9	36	2	MP:0008859
MousePheno	abnormal T wave	CTSL CTSV	2.30e-04	9	36	2	MP:0010505
MousePheno	increased heart left atrium size	CTSL CTSV	2.30e-04	9	36	2	MP:0008726
MousePheno	hypergranulosis	CTSL CTSV	2.30e-04	9	36	2	MP:0009600
MousePheno	focal dorsal hair loss	CTSL CTSV	2.30e-04	9	36	2	MP:0010202
MousePheno	abnormal effector memory CD4-positive, alpha-beta T cell number	ZC3H12C CTSL CTSV	2.51e-04	48	36	3	MP:0012770
MousePheno	abnormal effector memory CD4-positive, alpha-beta T cell morphology	ZC3H12C CTSL CTSV	2.51e-04	48	36	3	MP:0010843
MousePheno	abnormal lymph node cortex morphology	ZC3H12C CTSL CTSV	2.83e-04	50	36	3	MP:0002343
MousePheno	abnormal lymph node medulla morphology	CTSL CTSV	2.86e-04	10	36	2	MP:0002348
MousePheno	abnormal CD4-positive, alpha-beta memory T cell morphology	ZC3H12C CTSL CTSV	3.75e-04	55	36	3	MP:0010834
MousePheno	abnormal piliary canal morphology	CTSL CTSV	4.19e-04	12	36	2	MP:0030570
MousePheno	thick epidermis stratum granulosum	CTSL CTSV	4.19e-04	12	36	2	MP:0009599
MousePheno	lymph node inflammation	CTSL CTSV	4.19e-04	12	36	2	MP:0003865
MousePheno	abnormal dental pulp morphology	CTSL CTSV	4.19e-04	12	36	2	MP:0013250
MousePheno	increased CD4-positive, alpha-beta memory T cell number	ZC3H12C CTSL CTSV	4.62e-04	59	36	3	MP:0010835
MousePheno	aortic valve regurgitation	CTSL CTSV	4.94e-04	13	36	2	MP:0006047
MousePheno	atrioventricular valve regurgitation	CTSL CTSV	4.94e-04	13	36	2	MP:0006046
MousePheno	abnormal periodontal ligament morphology	CTSL CTSV	4.94e-04	13	36	2	MP:0003668
MousePheno	abnormal lysosome morphology	SPG11 CTSL CTSV	5.09e-04	61	36	3	MP:0005058
MousePheno	abnormal hair texture	CTSL CTSV EPG5	5.60e-04	63	36	3	MP:0002074
MousePheno	abnormal vacuole morphology	SPG11 CTSL CTSV	6.42e-04	66	36	3	MP:0020851
MousePheno	abnormal astrocyte morphology	CADM1 PSAP SPG11 EPG5	6.50e-04	155	36	4	MP:0002182
MousePheno	excessive scratching	CTSL CTSV	6.63e-04	15	36	2	MP:0001412
MousePheno	abnormal hair follicle outer root sheath morphology	CTSL CTSV	7.56e-04	16	36	2	MP:0010684
MousePheno	abnormal dental pulp cavity morphology	CTSL CTSV	7.56e-04	16	36	2	MP:0002819
MousePheno	orthokeratosis	CTSL CTSV	7.56e-04	16	36	2	MP:0009675
MousePheno	short hair	CTSL CTSV	7.56e-04	16	36	2	MP:0000417
MousePheno	abnormal thymus corticomedullary boundary morphology	CTSL CTSV	8.56e-04	17	36	2	MP:0009543
MousePheno	greasy coat	CTSL CTSV	8.56e-04	17	36	2	MP:0003849
MousePheno	axonal spheroids	PSAP EPG5	8.56e-04	17	36	2	MP:0010047
MousePheno	abnormal CD4-positive, alpha-beta memory T cell number	ZC3H12C CTSL CTSV	8.97e-04	74	36	3	MP:0012769
MousePheno	semilunar valve regurgitation	CTSL CTSV	9.61e-04	18	36	2	MP:0006049
MousePheno	abnormal external auditory canal morphology	CTSL CTSV	1.07e-03	19	36	2	MP:0006033
MousePheno	abnormal hair follicle orientation	CTSL CTSV	1.07e-03	19	36	2	MP:0000383
MousePheno	delayed hair appearance	CTSL CTSV	1.07e-03	19	36	2	MP:0000422
MousePheno	chronic inflammation	IL31RA CTSL CTSV	1.08e-03	79	36	3	MP:0002499
MousePheno	short vibrissae	CTSL CTSV	1.19e-03	20	36	2	MP:0001282
MousePheno	decreased alpha-beta T cell number	CADM1 ZC3H12C CTSL CTSV STAT5B	1.20e-03	315	36	5	MP:0012765
MousePheno	sparse hair	CTSL CTSV STAT5B	1.21e-03	82	36	3	MP:0000416
MousePheno	abnormal adipose tissue amount	RALGAPA1 EPRS1 IL31RA TM9SF1 DOCK7 SPG11 RAI1 STAT5B EPG5	1.30e-03	1077	36	9	MP:0005452
MousePheno	underdeveloped hair follicles	CTSL CTSV	1.31e-03	21	36	2	MP:0000382
MousePheno	thick dermal layer	CTSL CTSV	1.44e-03	22	36	2	MP:0001245
MousePheno	abnormal heart left atrium morphology	CTSL CTSV	1.44e-03	22	36	2	MP:0003923
MousePheno	enlarged sebaceous gland	CTSL CTSV	1.58e-03	23	36	2	MP:0000652
MousePheno	axon degeneration	PSAP SPG11 EPG5	1.63e-03	91	36	3	MP:0005405
MousePheno	abnormal hippocampus layer morphology	PSAP SPG11 EPG5	1.68e-03	92	36	3	MP:0000813
MousePheno	shiny skin	CTSL CTSV	1.72e-03	24	36	2	MP:0001196
MousePheno	increased central memory CD4-positive, alpha-beta T cell number	CTSL CTSV	1.72e-03	24	36	2	MP:0010841
MousePheno	abnormal CD8-positive, alpha-beta T cell number	CADM1 ZC3H12C CTSL CTSV STAT5B	1.95e-03	352	36	5	MP:0008077
MousePheno	adipose tissue phenotype	RALGAPA1 EPRS1 IL31RA TM9SF1 DOCK7 SPG11 STRA6 RAI1 STAT5B EPG5	2.00e-03	1383	36	10	MP:0005375
MousePheno	insulitis	CTSL CTSV	2.02e-03	26	36	2	MP:0004031
MousePheno	cardiac valve regurgitation	CTSL CTSV	2.02e-03	26	36	2	MP:0009384
MousePheno	increased keratinocyte proliferation	CTSL CTSV	2.17e-03	27	36	2	MP:0009583
MousePheno	abnormal metabolism	EPRS1 SMTNL1 PSAP ABRAXAS1 TENT5A SPG11 STRA6 EPG5	2.20e-03	936	36	8	MP:0005266
MousePheno	astrocytosis	PSAP SPG11 EPG5	2.32e-03	103	36	3	MP:0003354
MousePheno	abnormal tail movements	CADM1 PSAP	2.51e-03	29	36	2	MP:0001391
MousePheno	abnormal autophagy	PSAP SPG11 EPG5	2.52e-03	106	36	3	MP:0008260
MousePheno	increased astrocyte number	PSAP SPG11 EPG5	2.59e-03	107	36	3	MP:0012065
MousePheno	abnormal central memory CD4-positive, alpha-beta T cell number	CTSL CTSV	2.68e-03	30	36	2	MP:0012771
MousePheno	abnormal central memory CD4-positive, alpha-beta T cell morphology	CTSL CTSV	2.68e-03	30	36	2	MP:0010840
MousePheno	abnormal heart valve physiology	CTSL CTSV	2.68e-03	30	36	2	MP:0011926
MousePheno	abnormal CD8-positive, alpha beta T cell morphology	CADM1 ZC3H12C CTSL CTSV STAT5B	2.69e-03	379	36	5	MP:0005010
Domain	Latrophilin	ADGRL1 ADGRL2 ADGRL3	1.92e-08	3	51	3	PF02354
Domain	GPCR_2_latrophilin_rcpt_C	ADGRL1 ADGRL2 ADGRL3	1.92e-08	3	51	3	IPR003334
Domain	Lectin_gal-bd_dom	ADGRL1 ADGRL2 ADGRL3	1.91e-07	5	51	3	IPR000922
Domain	Gal_Lectin	ADGRL1 ADGRL2 ADGRL3	1.91e-07	5	51	3	PF02140
Domain	SUEL_LECTIN	ADGRL1 ADGRL2 ADGRL3	1.91e-07	5	51	3	PS50228
Domain	GPCR_2_latrophilin	ADGRL1 ADGRL2 ADGRL3	1.91e-07	5	51	3	IPR003924
Domain	GAIN_dom_N	ADGRL1 ADGRL2 ADGRL3	3.12e-06	11	51	3	IPR032471
Domain	GAIN	ADGRL1 ADGRL2 ADGRL3	3.12e-06	11	51	3	PF16489
Domain	Olfac-like_dom	ADGRL1 ADGRL2 ADGRL3	5.38e-06	13	51	3	IPR003112
Domain	OLF	ADGRL1 ADGRL2 ADGRL3	5.38e-06	13	51	3	SM00284
Domain	OLF	ADGRL1 ADGRL2 ADGRL3	5.38e-06	13	51	3	PF02191
Domain	OLF	ADGRL1 ADGRL2 ADGRL3	5.38e-06	13	51	3	PS51132
Domain	HormR	ADGRL1 ADGRL2 ADGRL3	4.23e-05	25	51	3	SM00008
Domain	HRM	ADGRL1 ADGRL2 ADGRL3	5.99e-05	28	51	3	PF02793
Domain	GPS	ADGRL1 ADGRL2 ADGRL3	1.08e-04	34	51	3	SM00303
Domain	GPCR_2_secretin-like_CS	ADGRL1 ADGRL2 ADGRL3	1.08e-04	34	51	3	IPR017983
Domain	GPS	ADGRL1 ADGRL2 ADGRL3	1.18e-04	35	51	3	PF01825
Domain	GPS	ADGRL1 ADGRL2 ADGRL3	1.29e-04	36	51	3	PS50221
Domain	GPS	ADGRL1 ADGRL2 ADGRL3	1.40e-04	37	51	3	IPR000203
Domain	Inhibitor_I29	CTSL CTSV	1.52e-04	7	51	2	PF08246
Domain	Prot_inhib_I29	CTSL CTSV	1.52e-04	7	51	2	IPR013201
Domain	Inhibitor_I29	CTSL CTSV	1.52e-04	7	51	2	SM00848
Domain	G_PROTEIN_RECEP_F2_1	ADGRL1 ADGRL2 ADGRL3	1.76e-04	40	51	3	PS00649
Domain	G_PROTEIN_RECEP_F2_3	ADGRL1 ADGRL2 ADGRL3	1.76e-04	40	51	3	PS50227
Domain	GPCR_2_extracellular_dom	ADGRL1 ADGRL2 ADGRL3	1.76e-04	40	51	3	IPR001879
Domain	Pept_asp_AS	CTSL CTSV	3.24e-04	10	51	2	IPR025661
Domain	G_PROTEIN_RECEP_F2_2	ADGRL1 ADGRL2 ADGRL3	3.43e-04	50	51	3	PS00650
Domain	7tm_2	ADGRL1 ADGRL2 ADGRL3	3.43e-04	50	51	3	PF00002
Domain	Pept_his_AS	CTSL CTSV	3.96e-04	11	51	2	IPR025660
Domain	Pept_C1	CTSL CTSV	5.59e-04	13	51	2	SM00645
Domain	Peptidase_C1A_C	CTSL CTSV	5.59e-04	13	51	2	IPR000668
Domain	Peptidase_C1	CTSL CTSV	5.59e-04	13	51	2	PF00112
Domain	Peptidase_C1A	CTSL CTSV	5.59e-04	13	51	2	IPR013128
Domain	GPCR_2-like	ADGRL1 ADGRL2 ADGRL3	5.88e-04	60	51	3	IPR017981
Domain	GPCR_2_secretin-like	ADGRL1 ADGRL2 ADGRL3	5.88e-04	60	51	3	IPR000832
Domain	G_PROTEIN_RECEP_F2_4	ADGRL1 ADGRL2 ADGRL3	6.17e-04	61	51	3	PS50261
Domain	THIOL_PROTEASE_CYS	CTSL CTSV	2.28e-03	26	51	2	PS00139
Domain	THIOL_PROTEASE_ASN	CTSL CTSV	2.46e-03	27	51	2	PS00640
Domain	THIOL_PROTEASE_HIS	CTSL CTSV	2.46e-03	27	51	2	PS00639
Domain	Pept_cys_AS	CTSL CTSV	2.64e-03	28	51	2	IPR000169
Domain	CUB	NETO2 C1S	7.92e-03	49	51	2	PF00431
Pathway	WP_GPCRS_CLASS_B_SECRETINLIKE	ADGRL1 ADGRL2 ADGRL3	2.98e-05	24	36	3	M39643
Pathway	WP_GPCRS_CLASS_B_SECRETINLIKE	ADGRL1 ADGRL2 ADGRL3	2.98e-05	24	36	3	MM15992
Pathway	REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES	SPOCK3 CTSL CTSV	1.21e-04	38	36	3	MM14611
Pathway	REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES	CTSL CTSV	1.76e-04	8	36	2	M27796
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	CTSL CTSV	3.44e-04	11	36	2	M525
Pathway	REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR	CTSL CTSV	4.86e-04	13	36	2	M593
Pathway	REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR	CTSL CTSV	4.86e-04	13	36	2	MM14659
Pathway	WP_ENDOCHONDRAL_OSSIFICATION	CTSL CTSV STAT5B	6.27e-04	66	36	3	MM15875
Pathway	WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS	DKK1 CTSL CTSV	8.41e-04	73	36	3	MM15906
Pubmed	A family of heptahelical receptors with adhesion-like domains: a marriage between two super families.	ADGRL1 ADGRL2 ADGRL3	3.15e-09	3	52	3	10994649
Pubmed	The multiple actions of black widow spider toxins and their selective use in neurosecretion studies.	ADGRL1 ADGRL2 ADGRL3	3.15e-09	3	52	3	15066411
Pubmed	Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.	PSAP CTSL CTSV	3.15e-09	3	52	3	18292516
Pubmed	alpha-Latrotoxin and its receptors: neurexins and CIRL/latrophilins.	ADGRL1 ADGRL2 ADGRL3	3.15e-09	3	52	3	11520923
Pubmed	The calcium-independent receptor for alpha-latrotoxin from human and rodent brains interacts with members of the ProSAP/SSTRIP/Shank family of multidomain proteins.	ADGRL1 ADGRL2 ADGRL3	6.28e-08	6	52	3	10964907
Pubmed	Lysosomal processing of progranulin.	PSAP CTSL CTSV	1.76e-07	8	52	3	28835281
Pubmed	Cartography of teneurin and latrophilin expression reveals spatiotemporal axis heterogeneity in the mouse hippocampus during development.	ADGRL1 ADGRL2 ADGRL3	3.75e-07	10	52	3	38713721
Pubmed	Identification of a membrane-associated cysteine protease with possible dual roles in the endoplasmic reticulum and protein storage vacuole.	CTSL CTSV	2.19e-06	2	52	2	11022031
Pubmed	B-cell lymphopoiesis is regulated by cathepsin L.	CTSL CTSV	2.19e-06	2	52	2	23585893
Pubmed	Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus.	CTSL CTSV	2.19e-06	2	52	2	9545226
Pubmed	Cathepsin L gene expression and promoter activation in rodent granulosa cells.	CTSL CTSV	2.19e-06	2	52	2	14563703
Pubmed	Cathepsin L is crucial for the development of early experimental diabetic nephropathy.	CTSL CTSV	2.19e-06	2	52	2	27575559
Pubmed	Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2alpha during inflammatory conditions.	CTSL CTSV	2.19e-06	2	52	2	19801522
Pubmed	Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L.	CTSL CTSV	2.19e-06	2	52	2	11972068
Pubmed	Identification of procathepsin L (pCTS-L)-neutralizing monoclonal antibodies to treat potentially lethal sepsis.	CTSL CTSV	2.19e-06	2	52	2	36735789
Pubmed	Cathepsin L plays an active role in involution of the mouse mammary gland.	CTSL CTSV	2.19e-06	2	52	2	12815617
Pubmed	Cathepsin L promotes Vascular Intimal Hyperplasia after Arterial Injury.	CTSL CTSV	2.19e-06	2	52	2	28332696
Pubmed	Cathepsin L inhibition prevents murine autoimmune diabetes via suppression of CD8(+) T cell activity.	CTSL CTSV	2.19e-06	2	52	2	20877570
Pubmed	Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice.	CTSL CTSV	2.19e-06	2	52	2	19900452
Pubmed	Impaired turnover of autophagolysosomes in cathepsin L deficiency.	CTSL CTSV	2.19e-06	2	52	2	20536383
Pubmed	Response to comment on "Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell number".	CTSL CTSV	2.19e-06	2	52	2	16621972
Pubmed	Latrophilin receptors: novel bronchodilator targets in asthma.	ADGRL1 ADGRL3	2.19e-06	2	52	2	27325752
Pubmed	Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression.	CTSL CTSV	2.19e-06	2	52	2	25957406
Pubmed	Cathepsin L regulates pathogenicCD4 T cells in experimental autoimmune encephalomyelitis.	CTSL CTSV	2.19e-06	2	52	2	33540247
Pubmed	The protease cathepsin L regulates Th17 cell differentiation.	CTSL CTSV	2.19e-06	2	52	2	26343333
Pubmed	Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice.	CTSL CTSV	2.19e-06	2	52	2	16636100
Pubmed	Cloning, genomic organization, and chromosomal localization of human cathepsin L.	CTSL CTSV	2.19e-06	2	52	2	8419312
Pubmed	Cathepsin L Regulates Metabolic Networks Controlling Rapid Cell Growth and Proliferation.	CTSL CTSV	2.19e-06	2	52	2	31010818
Pubmed	Increased nucleolar localization of SpiA3G in classically but not alternatively activated macrophages.	CTSL CTSV	2.19e-06	2	52	2	20338168
Pubmed	Thymocyte expression of cathepsin L is essential for NKT cell development.	CTSL CTSV	2.19e-06	2	52	2	12368909
Pubmed	Cloning and characterization of a mouse cysteine proteinase.	CTSL CTSV	2.19e-06	2	52	2	3533924
Pubmed	Surface activation of pro-cathepsin L.	CTSL CTSV	2.19e-06	2	52	2	1482371
Pubmed	Impaired hair follicle morphogenesis and cycling with abnormal epidermal differentiation in nackt mice, a cathepsin L-deficient mutation.	CTSL CTSV	2.19e-06	2	52	2	12163394
Pubmed	Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice.	CTSL CTSV	2.19e-06	2	52	2	20347002
Pubmed	Cathepsin L coexists with Cytotoxic T-lymphocyte Antigen-2 alpha in distinct regions of the mouse brain.	CTSL CTSV	2.19e-06	2	52	2	27586811
Pubmed	Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy.	CTSL CTSV	2.19e-06	2	52	2	15154914
Pubmed	Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways.	CTSL CTSV	2.19e-06	2	52	2	23608608
Pubmed	Autophagy and cathepsin L are involved in the antinociceptive effect of DMBC in a mouse acetic acid-writhing model.	CTSL CTSV	2.19e-06	2	52	2	23912553
Pubmed	Developmental expression of cathepsin L and c-rasHa in the mouse placenta.	CTSL CTSV	2.19e-06	2	52	2	1751032
Pubmed	Inhibition of cathepsin L alleviates the microglia-mediated neuroinflammatory responses through caspase-8 and NF-κB pathways.	CTSL CTSV	2.19e-06	2	52	2	29154036
Pubmed	Peripheral cathepsin L inhibition induces fat loss in C. elegans and mice through promoting central serotonin synthesis.	CTSL CTSV	2.19e-06	2	52	2	31771567
Pubmed	Cathepsin L Helps to Defend Mice from Infection with Influenza A.	CTSL CTSV	2.19e-06	2	52	2	27716790
Pubmed	The radiation-induced nackt (nkt) allele is a loss-of-function mutation of the mouse cathepsin L gene.	CTSL CTSV	2.19e-06	2	52	2	16393949
Pubmed	Cathepsin L in bone marrow-derived cells is required for retinal and choroidal neovascularization.	CTSL CTSV	2.19e-06	2	52	2	20304958
Pubmed	Characterization and comparative mapping of the porcine CTSL gene indicates a novel synteny between HSA9q21-->q22 and SSC10q11-->q12.	CTSL CTSV	2.19e-06	2	52	2	11978977
Pubmed	Comparison of cathepsin L synthesized by normal and transformed cells at the gene, message, protein, and oligosaccharide levels.	CTSL CTSV	2.19e-06	2	52	2	2275556
Pubmed	Evolution of placentally expressed cathepsins.	CTSL CTSV	2.19e-06	2	52	2	12054558
Pubmed	The CD4 T cell-deficient mouse mutation nackt (nkt) involves a deletion in the cathepsin L (CtsI) gene.	CTSL CTSV	2.19e-06	2	52	2	11398968
Pubmed	Cathepsin L is involved in proliferation and invasion of breast cancer cells.	CTSL CTSV	2.19e-06	2	52	2	26639231
Pubmed	A variant of pulmonary alveolar microlithiasis in nackt mice.	CTSL CTSV	2.19e-06	2	52	2	12014504
Pubmed	An alternate targeting pathway for procathepsin L in mouse fibroblasts.	CTSL CTSV	2.19e-06	2	52	2	11929604
Pubmed	Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis.	CTSL CTSV	2.19e-06	2	52	2	20023699
Pubmed	Cathepsin L protects mice from mycoplasmal infection and is essential for airway lymphangiogenesis.	CTSL CTSV	2.19e-06	2	52	2	23600672
Pubmed	Mice that express enzymatically inactive cathepsin L exhibit abnormal spermatogenesis.	CTSL CTSV	2.19e-06	2	52	2	12533435
Pubmed	Impaired cathepsin L gene expression in skeletal muscle is associated with type 2 diabetes.	CTSL CTSV	2.19e-06	2	52	2	12941783
Pubmed	The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling.	CTSL CTSV	2.19e-06	2	52	2	12000732
Pubmed	Latrophilin GPCR signaling mediates synapse formation.	ADGRL2 ADGRL3	2.19e-06	2	52	2	33646123
Pubmed	Cathepsin L was involved in vascular aging by mediating phenotypic transformation of vascular cells.	CTSL CTSV	2.19e-06	2	52	2	36206719
Pubmed	Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell number.	CTSL CTSV	2.19e-06	2	52	2	15905545
Pubmed	Cathepsin-L, a key molecule in the pathogenesis of drug-induced and I-cell disease-mediated gingival overgrowth: a study with cathepsin-L-deficient mice.	CTSL CTSV	2.19e-06	2	52	2	12466121
Pubmed	Sequence and expression of the cDNA for MEP (major excreted protein), a transformation-regulated secreted cathepsin.	CTSL CTSV	2.19e-06	2	52	2	3689328
Pubmed	Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly.	CTSL CTSV	2.19e-06	2	52	2	10516062
Pubmed	Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.	CTSL CTSV	2.19e-06	2	52	2	19096818
Pubmed	Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling.	CTSL CTSV	2.19e-06	2	52	2	11023992
Pubmed	Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.	CTSL CTSV	2.19e-06	2	52	2	17671649
Pubmed	Close relationship of the major excreted protein of transformed murine fibroblasts to thiol-dependent cathepsins.	CTSL CTSV	2.19e-06	2	52	2	3755373
Pubmed	[Effect of bushen tiaojing recipe and xiaoyao pill on expression of cathepsin-L mRNA in gonadotropin-primed mice].	CTSL CTSV	2.19e-06	2	52	2	21434350
Pubmed	Alterations during positive selection in the thymus of nackt CD4-deficient mice.	CTSL CTSV	2.19e-06	2	52	2	11119260
Pubmed	Contribution of cathepsin L to secretome composition and cleavage pattern of mouse embryonic fibroblasts.	CTSL CTSV	2.19e-06	2	52	2	21972973
Pubmed	Cell type-specific functions of the lysosomal protease cathepsin L in the heart.	CTSL CTSV	2.19e-06	2	52	2	17942402
Pubmed	Cathepsin L stabilizes the histone modification landscape on the Y chromosome and pericentromeric heterochromatin.	CTSL CTSV	2.19e-06	2	52	2	16705169
Pubmed	Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels.	CTSL CTSV	2.19e-06	2	52	2	18469859
Pubmed	Cortical Thymocytes Along With Their Selecting Ligands Are Required for the Further Thymic Maturation of NKT Cells in Mice.	CTSL CTSV	2.19e-06	2	52	2	32457751
Pubmed	The human cysteine protease cathepsin V can compensate for murine cathepsin L in mouse epidermis and hair follicles.	CTSL CTSV	2.19e-06	2	52	2	15679121
Pubmed	Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts.	CTSL CTSV	2.19e-06	2	52	2	2835398
Pubmed	Cloning and expression of the gene for the major excreted protein of transformed mouse fibroblasts. A secreted lysosomal protease regulated by transformation.	CTSL CTSV	2.19e-06	2	52	2	2826441
Pubmed	Inhibition of cysteine protease cathepsin L increases the level and activity of lysosomal glucocerebrosidase.	CTSL CTSV	2.19e-06	2	52	2	38329128
Pubmed	Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: amino-acid-sequence identities with procathepsin L.	CTSL CTSV	2.19e-06	2	52	2	8554545
Pubmed	Cathepsin L plays a major role in cholecystokinin production in mouse brain cortex and in pituitary AtT-20 cells: protease gene knockout and inhibitor studies.	CTSL CTSV	2.19e-06	2	52	2	19589362
Pubmed	Cathepsin L is essential for onset of autoimmune diabetes in NOD mice.	CTSL CTSV	2.19e-06	2	52	2	16184198
Pubmed	The lysosomal cysteine protease cathepsin L regulates keratinocyte proliferation by control of growth factor recycling.	CTSL CTSV	2.19e-06	2	52	2	16079282
Pubmed	Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice.	CTSL CTSV	2.19e-06	2	52	2	21868704
Pubmed	Cathepsin-L contributes to cardiac repair and remodelling post-infarction.	CTSL CTSV	2.19e-06	2	52	2	21147810
Pubmed	Cathepsin L proteolytically processes histone H3 during mouse embryonic stem cell differentiation.	CTSL CTSV	2.19e-06	2	52	2	18957203
Pubmed	Latrophilin GPCRs direct synapse specificity by coincident binding of FLRTs and teneurins.	ADGRL2 ADGRL3	2.19e-06	2	52	2	30792275
Pubmed	Nackt (nkt), a new hair loss mutation of the mouse with associated CD4 deficiency.	CTSL CTSV	6.57e-06	3	52	2	10199917
Pubmed	Cathepsin Protease Controls Copper and Cisplatin Accumulation via Cleavage of the Ctr1 Metal-binding Ectodomain.	CTSL CTSV	6.57e-06	3	52	2	27143361
Pubmed	Neuronal loss and brain atrophy in mice lacking cathepsins B and L.	CTSL CTSV	6.57e-06	3	52	2	12048238
Pubmed	Human and mouse perforin are processed in part through cleavage by the lysosomal cysteine proteinase cathepsin L.	CTSL CTSV	6.57e-06	3	52	2	20497254
Pubmed	Fitness of heterozygotes of deleterious recessive mutations in the mouse.	CTSL CTSV	6.57e-06	3	52	2	5563943
Pubmed	Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.	CTSL CTSV	6.57e-06	3	52	2	18362148
Pubmed	Up-regulation of cathepsin B and cathepsin L activities in scrapie-infected mouse Neuro2a cells.	CTSL CTSV	6.57e-06	3	52	2	12867662
Pubmed	The PI3K regulatory subunits p55α and p50α regulate cell death in vivo.	CTSL CTSV	6.57e-06	3	52	2	24902901
Pubmed	Deletion of cysteine cathepsins B or L yields differential impacts on murine skin proteome and degradome.	CTSL CTSV	6.57e-06	3	52	2	23233448
Pubmed	Cathepsin L activity controls adipogenesis and glucose tolerance.	CTSL CTSV	6.57e-06	3	52	2	17643114
Pubmed	Invariant chain controls the activity of extracellular cathepsin L.	CTSL CTSV	6.57e-06	3	52	2	12417635
Pubmed	Cathepsins D and L reduce the toxicity of advanced glycation end products.	CTSL CTSV	6.57e-06	3	52	2	22245096
Pubmed	Conditional Gene Targeting Reveals Cell Type-Specific Roles of the Lysosomal Protease Cathepsin L in Mammary Tumor Progression.	CTSL CTSV	6.57e-06	3	52	2	32707827
Pubmed	Secreted cathepsin L generates endostatin from collagen XVIII.	CTSL CTSV	6.57e-06	3	52	2	10716919
Pubmed	Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis.	CTSL CTSV	6.57e-06	3	52	2	23811845
GeneFamily	Adhesion G protein-coupled receptors, subfamily L	ADGRL1 ADGRL2 ADGRL3	1.65e-08	4	30	3	918
GeneFamily	Cathepsins	CTSL CTSV	2.76e-04	15	30	2	470
GeneFamily	Complement system\|Sushi domain containing	C1S CFHR3	1.62e-03	36	30	2	492
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	C1S CFHR3	4.01e-03	57	30	2	1179
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPOCK3 ZC3H12C ADGRL2 ITM2B ADGRL3	2.16e-06	180	52	5	544fb373a3346186ec60afe2cfcf141bb04a1eed
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPOCK3 ZC3H12C ADGRL2 ITM2B ADGRL3	2.16e-06	180	52	5	30cf3c7ee29694eaccb89bf8053a82037d5c9f1d
ToppCell	5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DKK1 PRICKLE2 C1S CTSL CFHR3	2.22e-06	181	52	5	ab66a89f316b935d9ba1277426d976b1e9e39757
ToppCell	Control-Endothelial-Endothelial-Activated_Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPOCK3 PRICKLE2 ZC3H12C ADGRL2 ADGRL3	2.35e-06	183	52	5	e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell	facs-Bladder-nan-18m\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RND1 PSAP SPOCK3 STRA6 CTSL	2.47e-06	185	52	5	3e00879466e626aa8604efecfc4678d64f54dbfc
ToppCell	facs-Bladder-nan-18m-Epithelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RND1 PSAP SPOCK3 STRA6 CTSL	2.47e-06	185	52	5	3dc5812c961ff209f197ff4cbfb90009c0537550
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPOCK3 PRICKLE2 ZC3H12C ADGRL2 ADGRL3	2.61e-06	187	52	5	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	Control-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	NETO2 PRICKLE2 ADGRL2 ITM2B ADGRL3	2.68e-06	188	52	5	88b3415e33db81726dd29c1f50c886e057af50a0
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPOCK3 PRICKLE2 ZC3H12C ADGRL2 ADGRL3	2.82e-06	190	52	5	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	COPD-Lymphoid-T_Regulatory\|Lymphoid / Disease state, Lineage and Cell class	KAT2B CADM1 NETO2 ZC3H12C STAT5B	2.89e-06	191	52	5	3ae18bc4e3dff49b5d5958da8ebc3f747274b69c
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RND1 SPOCK3 ZC3H12C ADGRL2 ADGRL3	2.89e-06	191	52	5	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NETO2 PRICKLE2 ADGRL2 ITM2B ADGRL3	2.97e-06	192	52	5	7197e401e563441ab94815f7619e032ebef9e586
ToppCell	distal-Endothelial-Capillary_Aerocyte-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NETO2 PRICKLE2 ADGRL2 ITM2B ADGRL3	3.62e-06	200	52	5	d36236c7703b759309c8347f44900fc4bed377f0
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	NETO2 PRICKLE2 ADGRL2 ITM2B	3.39e-05	157	52	4	84f629b7f589ca8a1abc220fa740c4a6fdc1b579
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CADM1 ART3 TEKT5 ADGRL3	3.83e-05	162	52	4	d28b2ea1d2c8f3c6a107991573471b6d0c49c4ae
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CADM1 ART3 TEKT5 ADGRL3	3.83e-05	162	52	4	eed223e61c8162a2fe004ab4e09de5e037be7553
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Neural-neural_cell-Schwann_Cell_/_Neural-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CADM1 ART3 TEKT5 ADGRL3	3.83e-05	162	52	4	5bbd7130d4dad9035e73a439dda568195c136f31
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Neural\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	CADM1 ART3 TEKT5 ADGRL3	3.83e-05	162	52	4	e35ddce830e20ebeac1a2c405293fc4a5323dd4a
ToppCell	PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ART3 ICE2 PRICKLE2 ADGRL2	4.42e-05	168	52	4	c7021748003e5949f7caf7b3291c5bad294948c1
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRICKLE2 C1S ADGRL2 ADGRL3	4.52e-05	169	52	4	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DKK1 PRICKLE2 C1S ADGRL3	5.41e-05	177	52	4	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DKK1 PRICKLE2 C1S ADGRL3	5.41e-05	177	52	4	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRICKLE2 C1S ADGRL2 ADGRL3	5.77e-05	180	52	4	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCDC1 ART3 ADGRL2 ATP4A	6.29e-05	184	52	4	30fddbc9696476d4d7f08e53f84ea994a4ed873a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCDC1 ART3 ADGRL2 ATP4A	6.29e-05	184	52	4	96926efa220f03d0787322c9519bb9e8f64f74d0
ToppCell	(1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)\|World / Stress and Cell class	CADM1 PSAP ITM2B CTSL	6.42e-05	185	52	4	b8cd94cf18308b514fc61557550225794ffd2860
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPOCK3 ZC3H12C ADGRL2 ADGRL3	6.69e-05	187	52	4	f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Adult / Lineage, Cell type, age group and donor	NETO2 PRICKLE2 ADGRL2 ADGRL3	6.83e-05	188	52	4	e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPOCK3 ZC3H12C ADGRL2 ADGRL3	6.83e-05	188	52	4	73f6ec915934154f435a376cb274b058ff7c5f35
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRICKLE2 C1S ADGRL3 CFHR3	6.83e-05	188	52	4	997dcfc4f08738ab398d8abc15e4fd2fc6619862
ToppCell	LAM-Endothelial-VasEndo-1\|Endothelial / Condition, Lineage and Cell class	NETO2 PRICKLE2 ADGRL2 ITM2B	6.83e-05	188	52	4	f24c33d960ca93459584a79ff8f0ec20db6a34d5
ToppCell	Control-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPOCK3 PRICKLE2 ZC3H12C ADGRL3	6.98e-05	189	52	4	5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1
ToppCell	Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NETO2 PRICKLE2 ADGRL2 ADGRL3	7.12e-05	190	52	4	0a351609a72fd638c84b2435782e312ee6a33aac
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NETO2 PRICKLE2 ADGRL2 ADGRL3	7.27e-05	191	52	4	1de0bdfd13bd930691564c2673f2e66393bc0255
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPOCK3 ZC3H12C ADGRL2 ADGRL3	7.41e-05	192	52	4	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPOCK3 ZC3H12C ADGRL2 ADGRL3	7.56e-05	193	52	4	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRICKLE2 ZC3H12C ADGRL2 ADGRL3	7.56e-05	193	52	4	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRICKLE2 ZC3H12C ADGRL2 ADGRL3	7.56e-05	193	52	4	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	IPF-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	NETO2 PRICKLE2 ADGRL2 ITM2B	7.72e-05	194	52	4	777ce41c3f22c591e2d81120f189b834e53ffb4b
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2\|World / Primary Cells by Cluster	CADM1 NETO2 SPOCK3 TENT5A	7.72e-05	194	52	4	b42fd64b0fb95434a9e4e6586f31d26114a4074b
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10\|World / Primary Cells by Cluster	CADM1 NETO2 SPOCK3 TENT5A	7.72e-05	194	52	4	81e7bc6516ab8d02ccd1c76a56a3533b788c27c8
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPOCK3 ZC3H12C ADGRL2 ADGRL3	7.72e-05	194	52	4	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SPOCK3 ZC3H12C ADGRL2 ADGRL3	7.72e-05	194	52	4	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CADM1 ART3 C1S ADGRL3	7.87e-05	195	52	4	7a32a8535c29b819dacba901d0658280a2631c94
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRICKLE2 ADGRL2 ITM2B ADGRL3	7.87e-05	195	52	4	e8992c549dad9a88d2b8d01039a8d02a950b29b4
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CADM1 ART3 C1S ADGRL3	7.87e-05	195	52	4	4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRICKLE2 C1S ADGRL2 ADGRL3	8.03e-05	196	52	4	2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell	proximal-Endothelial-Capillary-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NETO2 ADGRL2 CTSV ADGRL3	8.19e-05	197	52	4	ddb8ea895f0f34d4f20a0740b708fa0f3e378801
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CADM1 C1S ITM2B ADGRL3	8.19e-05	197	52	4	2e3d64648a1e4f01b9256a96b94b8a640ee1824c
ToppCell	proximal-Endothelial-Capillary\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NETO2 ADGRL2 CTSV ADGRL3	8.19e-05	197	52	4	53baef54bd85c60ae24a3c163b3a3d937fb6ff0b
ToppCell	proximal-3-Endothelial-Capillary\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NETO2 ADGRL2 CTSV ADGRL3	8.19e-05	197	52	4	a1a61c03d67272693ec23e0d15f0a12bf618e2da
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CADM1 C1S ITM2B ADGRL3	8.19e-05	197	52	4	d9e196c8b4a6ede4733946dbdba3331534954beb
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRICKLE2 C1S ADGRL2 ADGRL3	8.35e-05	198	52	4	7582ee9ec8a87ecb094201f1f9191b412f9d2875
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CADM1 C1S ITM2B ADGRL3	8.51e-05	199	52	4	05777e92344aedabfb5a72207c6632dc64205534
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CADM1 C1S CTSL ADGRL3	8.51e-05	199	52	4	bdedcc7c8f3be0996200c882dda82fb2658655c0
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CADM1 C1S ADGRL2 ADGRL3	8.51e-05	199	52	4	56d72da6a5fab9cbb2975fe6f87a631debaba6a8
ToppCell	distal-3-Endothelial-Capillary_Aerocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	NETO2 PRICKLE2 ADGRL2 ITM2B	8.68e-05	200	52	4	e12598a097dd9c4cbf9bb85bfa3057722ef73ad5
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CADM1 PSAP ITM2B CTSL	8.68e-05	200	52	4	a2548b0c77ba1616638351b111cce2fe0cacaa95
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CADM1 PSAP ITM2B CTSL	8.68e-05	200	52	4	e4a499b69554f78161c2c47199da77c201910e73
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SPOCK3 ADGRL2 ITM2B ADGRL3	8.68e-05	200	52	4	58a7ece7dfdf6c46f2a50cbcb580574dec14c748
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	SPOCK3 ZC3H12C ADGRL2 ITM2B	8.68e-05	200	52	4	432384faeade8e609154fab3d96c955a8ec868dd
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NETO2 PRICKLE2 ADGRL2 ADGRL3	8.68e-05	200	52	4	105c67e4f5eff036013d655c8e8ac577d32dae2e
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SPOCK3 ZC3H12C ADGRL2 ITM2B	8.68e-05	200	52	4	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	LA-04._Ventricular_Cardiomyocyte_I\|LA / Chamber and Cluster_Paper	KAT2B B3GNT3 ADGRL2	2.88e-04	110	52	3	34dcd1e1e16e8b6088ff9a7a40532e8bd000c121
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Nxph2_Sla\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ART3 TEKT5 NXPH2	5.13e-04	134	52	3	6d97fa07f55ae20c17b9d5262e893957cccc6dba
ToppCell	PND01-03-samps-Mesenchymal-Pericyte-pericyte_E\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	ART3 C1S PP2D1	5.24e-04	135	52	3	35928195cf34f055b353562c96f451aef2344d64
ToppCell	COVID-19_Severe-Classical_Monocyte-\|Classical_Monocyte / Disease condition and Cell class	PRICKLE2 C1S ADGRL3	5.36e-04	136	52	3	e272d11bb52f890f6681cc9384aeac27976ec650
ToppCell	PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRICKLE2 C1S ADGRL3	5.47e-04	137	52	3	12caa8ed7cc9e7a0f78c14ad5efe2fc28c3ce9be
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	NETO2 PRICKLE2 ADGRL2	5.71e-04	139	52	3	2fdc8f36510aff24abbc79ef2a842db75a85f946
ToppCell	343B-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	NETO2 PRICKLE2 ADGRL2	5.71e-04	139	52	3	5970a654c64e3b54f9d18c102f5b125eec892fc5
ToppCell	COVID-19_Severe-Classical_Monocyte-\|COVID-19_Severe / Disease condition and Cell class	PRICKLE2 C1S ADGRL3	5.83e-04	140	52	3	cade44740dd3acca7789591aa5a7935d48d5cbee
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SMTNL1 STRA6 ATP4A	6.20e-04	143	52	3	27e06327f96cb72bd111ea6ece6307e5ebb3a146
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-hematopoietic_progenitor\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SMTNL1 STRA6 ATP4A	6.20e-04	143	52	3	4edef95ae2a1ef4fc4b0d4fadf75bfc54b583932
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	NETO2 SPOCK3 NXPH2	6.45e-04	145	52	3	8b13b576fd2e6e33ccb146860a91a53cee0cdd4d
ToppCell	368C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	DKK1 ART3 C1S	7.40e-04	152	52	3	3a1414ba6a4972698c3262a00b124428835c35cb
ToppCell	368C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)\|368C / Donor, Lineage, Cell class and subclass (all cells)	DKK1 ART3 C1S	7.40e-04	152	52	3	ee7855d76a49d07a032677a4dc83aa6116d50518
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SPOCK3 TENT5A ITM2B	7.40e-04	152	52	3	fed80b467ec9e30c7f98bed6cc4f8c583b715e9e
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TEKT5 CTSV ADGRL3	7.83e-04	155	52	3	9a27558c457f05808af07190b7a5006b047f1d58
ToppCell	PBMC-Mild-Myeloid-cDC-cDC-cDC_3\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TEKT5 CTSV ADGRL3	7.83e-04	155	52	3	ab539c04f10276ae919d82b1c75f99a84eb695bf
ToppCell	droplet-Kidney-KIDNEY-30m-Myeloid-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL31RA CADM1 TENT5A	7.98e-04	156	52	3	6e60e860603a7e8194f437a574ff8e887f6083b8
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SPOCK3 TENT5A ITM2B	8.13e-04	157	52	3	516903469756c5fabfdf56d7bd59b3bdd7b44e39
ToppCell	AT1-AT2_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DKK1 C1S B3GNT3	8.28e-04	158	52	3	3bc51cfd37b289cc3e866b54ce55a298e5eff690
ToppCell	TCGA-Kidney-Solid_Tissue_Normal-Kidney-Kidney_normal_tissue-5\|TCGA-Kidney / Sample_Type by Project: Shred V9	STRA6 CTSV NXPH2	8.28e-04	158	52	3	34b284a62cc3fb90429ce579fd8cb8a60178091b
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TENT5A PFKFB2 CATSPERG	8.58e-04	160	52	3	955acb023ce4ccfac5073c9d693db87db3856187
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM5-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RND1 DKK1 ADGRL2	9.55e-04	166	52	3	006ced12f69ef13ddcba5a3891ddc7c18c384863
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM5\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	RND1 DKK1 ADGRL2	9.55e-04	166	52	3	ac28c8cac1e94be0c47fb862c5809c92cdaa11f3
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM5-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	RND1 DKK1 ADGRL2	9.55e-04	166	52	3	6bb3410e65c971acc458c472015afcec6de6e310
ToppCell	BAL-Mild-Myeloid-MoAM-MoAM5\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	RND1 DKK1 ADGRL2	9.55e-04	166	52	3	823ec03714884cb860a1260410feac8c536b6d06
ToppCell	droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ART3 PRICKLE2 B3GNT3	9.71e-04	167	52	3	a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RND1 ART3 B3GNT3	9.71e-04	167	52	3	774f3264318b002d0df5d06d41d645366038d0bf
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231\|Adult / Lineage, Cell type, age group and donor	PRICKLE2 ADGRL2 ADGRL3	9.71e-04	167	52	3	5af9127bae05768a5164d5708a4ad37edca99324
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CADM1 ART3 ADGRL3	9.88e-04	168	52	3	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs\|Fibroblasts / Location, Cell class and cell subclass	RND1 ABRAXAS1 C1S	1.01e-03	169	52	3	84b898a9fd8ced67c6a501d5cef6416f519902c4
ToppCell	facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B_+_C\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZMYND19 ABRAXAS1 ATP4A	1.01e-03	169	52	3	2a35846b0e0be0a19a5a04a86cbd72ce65257c8a
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122\|Adult / Lineage, Cell type, age group and donor	NETO2 PRICKLE2 ADGRL2	1.04e-03	171	52	3	bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCell	droplet-Lung-nan-21m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CADM1 ZC3H12C CATSPERG	1.04e-03	171	52	3	159ce6d5513008532dd7785b915b3fe7440cc4b2
ToppCell	droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ART3 PRICKLE2 ADGRL3	1.06e-03	172	52	3	073a503dc922e3e3ac3528e249b0f8b74402110b
ToppCell	Adult-Mesenchymal-vascular_smooth_muscle_cell\|Adult / Lineage, Cell type, age group and donor	DKK1 ART3 ADGRL3	1.06e-03	172	52	3	c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CADM1 ART3 C1S	1.06e-03	172	52	3	03a0aff6b7971093a4347b5ed12546d78374c56f
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CADM1 DCDC1 ZC3H12C	1.08e-03	173	52	3	922356a5b4c84607318ac24d7caa2e235b72b066
Computational	Genes upregulated in subsets of cells of a given type within various tumors	EPRS1 PSAP ITM2B CTSL	9.03e-06	50	29	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_10_PROTEIN_MATURATION
Disease	attention deficit hyperactivity disorder (implicated_via_orthology)	ADGRL1 ADGRL2 ADGRL3	1.55e-05	28	51	3	DOID:1094 (implicated_via_orthology)
Disease	otitis media (biomarker_via_orthology)	CTSL CTSV	3.92e-04	17	51	2	DOID:10754 (biomarker_via_orthology)
Disease	optic disc size measurement	KAT2B DCDC1 PCNX4 STRA6	4.38e-04	205	51	4	EFO_0004832
Disease	nephrotic syndrome (biomarker_via_orthology)	CTSL CTSV	7.89e-04	24	51	2	DOID:1184 (biomarker_via_orthology)
Disease	colorectal adenocarcinoma (is_marker_for)	STRA6 STAT5B	1.00e-03	27	51	2	DOID:0050861 (is_marker_for)
Disease	hyperthyroidism (biomarker_via_orthology)	CTSL CTSV	1.08e-03	28	51	2	DOID:7998 (biomarker_via_orthology)
Disease	muscular atrophy (biomarker_via_orthology)	CTSL CTSV	1.15e-03	29	51	2	DOID:767 (biomarker_via_orthology)
Disease	Complement deficiency disease	C1S CFHR3	1.49e-03	33	51	2	C0272242

Protein segments in the cluster

Peptide	Gene	Start	Entry
VYTIDIQKYIPCYQL	ABRAXAS1	56	Q6UWZ7
PYYLKINYSCEEKPS	CATSPERG	96	Q6ZRH7
CYKVTYRPLDPDNYD	PFKFB2	196	O60825
PLFYPCQYYLLKNEQ	EPG5	1066	Q9HCE0
RPLYQYVNYCNPELN	C16orf86	191	Q6ZW13
SYPYVAVDEICKYRP	CTSV	201	O60911
PGTYKYLEVQYDCVP	ADGRL1	116	O94910
YLEVQYDCVPYKVEQ	ADGRL1	121	O94910
PGTYKYLEVQYECVP	ADGRL3	111	Q9HAR2
YLEVQYECVPYKVEQ	ADGRL3	116	Q9HAR2
EQYEEQGPYIVYRKC	ACTL9	401	Q8TC94
KYLEVQYECVPYIFV	ADGRL2	121	O95490
QKVCPDYNYHSETPY	NXPH2	246	O95156
YCQPDAAVRTPEQYY	RAI1	321	Q7Z5J4
VCGYPVIVQKYKPYN	DCDC1	1241	M0R2J8
YVVYRQVCNSDPPCY	MAGEB6	341	Q8N7X4
LQPDDVYYCGIKYIK	ITM2B	81	Q9Y287
FTNCKEYNPPESEYY	KAT2B	796	Q92831
EYNPPESEYYKCANI	KAT2B	801	Q92831
LPAKPENISCVYYYR	IL31RA	21	Q8NI17
KLGYCAPPYIYVNQI	PCNX4	31	Q63HM2
YVPQEEVPVYENKYV	PYM1	36	Q9BRP8
QYYSCLPEEKVPYVN	PRICKLE2	51	Q7Z3G6
RYFCQLYTDPPQESY	CADM1	121	Q9BY67
PQSRVEYQCQPYYEL	CFHR3	231	Q02985
QFPVYVLPKVEYQAC	ICE2	766	Q659A1
PNKAYIQITYVEPYF	DOCK7	1906	Q96N67
NYPKPYPENSRCEYQ	C1S	191	P09871
KYYVPEVVTQNERYP	B3GNT3	251	Q9Y2A9
GNKYQTIDNYQPYPC	DKK1	71	O94907
FCQLYLNEKDYPPGY	ATP4A	566	P20648
IYTYPCIPEYEEKDH	DTWD1	121	Q8N5C7
AYYYCNPPPAEKTVK	UPF2	751	Q9HAU5
YNVYPTYDFACPIVD	EPRS1	371	P07814
LLTTYKKDYNPYPVC	SAXO1	101	Q8IYX7
DCYPETYVPTVFENY	RND1	36	Q92730
AVQAPVIQECYQPYY	TEKT5	26	Q96M29
DEVYSKYYTPVPCES	STAT5B	676	P51692
NYPDSYPPNKECIYI	NETO2	61	Q8NC67
RAECPQVPKIYKYYS	STRA6	191	Q9BX79
SYPYEATEESCKYNP	CTSL	201	P07711
YVYLDCYKLSPENCP	SPG11	1006	Q96JI7
YYECHYPPCTVIEKQ	ZMYND19	166	Q96E35
LYNLVSVYPDKYCPL	ZER1	706	Q7Z7L7
KYYLPYIFPNICKEN	RALGAPA1	246	Q6GYQ0
VPDSKCVYTYIQELY	SMTNL1	466	A8MU46
PYQKQCDQFVAEYEP	PSAP	446	P07602
QYIPLCDEDGYYKPT	SPOCK3	336	Q9BQ16
VAPSRPFVVYCQYKE	TRMT6	391	Q9UJA5
QPEAPYYYVNIEKTE	XKR3	416	Q5GH77
EQYPKCDSPVDIGYY	ZC3H12C	576	Q9C0D7
VTCYYQPAPYVADAN	TENT5A	401	Q96IP4
QETYHYYQLPVCCPE	TM9SF1	56	O15321
KYCIYNPENVETFPA	PP2D1	541	A8MPX8
NCIENLEYFQPIYVY	ART3	266	Q13508